SCHEMBL11148476

SCHEMBL11148476

CCN1C(=O)CSC1=NC(=O)Nc1c(C)cccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ RIPK1 Q13546 1/20 0.39
▸ HTT P42858 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ NLRP3 Q96P20 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ TP53 P04637 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11146421 0.94 L3MBTL1 (0.45) L3MBTL1HTTALDH1A1LMNAKMT2A
SCHEMBL11148675 0.90 L3MBTL1 (0.52) L3MBTL1HTTALDH1A1LMNAKMT2A
SCHEMBL11151463 0.89 L3MBTL1 (0.48) L3MBTL1HTTALDH1A1LMNANLRP3
SCHEMBL11148636 0.87 CYP1A2 (0.40) L3MBTL1HTTALDH1A1LMNAKMT2A
SCHEMBL11146126 0.86 RIPK1 (0.40) RIPK1ALDH1A1NLRP3KMT2AMAPT
SCHEMBL11141810 0.85 L3MBTL1 (0.45) L3MBTL1HTTALDH1A1NLRP3KMT2A
SCHEMBL11150764 0.84 L3MBTL1 (0.55) L3MBTL1HTTALDH1A1LMNAKMT2A
SCHEMBL11151136 0.82 L3MBTL1 (0.42) L3MBTL1ALDH1A1LMNAKMT2AEGFR
SCHEMBL11000472 0.80 GRM5 (0.39) RIPK1ALDH1A1LMNANLRP3KMT2A
SCHEMBL11146807 0.79 L3MBTL1 (0.47) L3MBTL1HTTALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4402964-A N-Aryl-N'-(3-methyl or ethyl-4-oxothiazolidinylidene)ureas useful for the treatment of epilepsy MCNEILAB, INC. (US) 1983-09-06 — — US disclosed
Send feedback